PACS | PACS GroupNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$46.68
+$1.10 (+2.41%)

PACS Group (PACS) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

The 50 SMA has sat above the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $46.68 vs 50 $44.26 / 200 $39.78
Projection
No cross projected
Test
No active test
Last cross
Golden cross 14 Oct 2025 ยท projected 28 bars out ยท tested 1 bar

Weekly

No weekly data

4-hour as of 3 Nov 16:00 ET

Price
above both $46.68 vs 50 $45.64 / 200 $43.91
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Cross history

1
cross on record since 2025
1 golden0 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
14 Oct 2025Golden moderatedaily28 bars out1 bar cross test

About PACS

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$30.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.